Abstract
There are many potential coagulation concerns observed in women contemplating pregnancy, as well as in women who are pregnant, or in labor and delivery, and in the postpartum state. This chapter explores issues related to both bleeding and thrombotic disorders of young women, and how they impact the pregnant state. Also, complications of pregnancy that can cause changes in platelet count or changes in coagulation status are explored. These include the hypertensive disorders of late pregnancy, such as preeclampsia, eclampsia, acute fatty liver of pregnancy, the HELLP syndrome, and the devastating catastrophic complication of amniotic fluid embolism. Also, management of anticoagulation during pregnancy is discussed, especially in the light of the teratogenic potential of coumadin. Those hematologic conditions that can contribute to multiple miscarriages, such as the lupus anticoagulant, are also discussed.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Amorim A, Santos LLC, Fundes A. Corticosteroid therapy for the prevention of respiratory distress syndrome in severe preeclampsia. Am J Obstet Gynecol. 1999;180(5):1283–8.
Bates SM, Greer IA, Middeldorp S, Veenstra DL, Praboulos AM, Vandvik PO. VTE, thrombophilia, antithrombotic therapy and pregnancy: antithrombotic therapy and prevention of thrombosis, 9th ed American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(2 Suppl):e691s–736.
Benson MD. Current concepts of immunology and diagnosis in amniotic fluid embolism. Clin Dev Immunol. 2012;Article ID 946576, 7 pages. doi:10.1155/2012/946576.
Bijsterveld NR, Middledorp S, Berends F, Büller HR. Monitoring therapy with vitamin K antagonists in patients with lupus anticoagulant: effect on different tests for INR determination. J Thromb Thrombolysis. 2000;9(3):263–9.
Burrows RF, Ray JG, Burrows EA. Bleeding risk and reproductive capacity among patients with factor XIII deficiency: a case presentation and review of the literature. Obstet Gynecol Surv. 2000;55(20):103–8.
Cahill AG, Madones GA, Odigo AO, Stamilio DM. Magnesium for seizure prophylaxis in patients with mild preeclampsia. Obstet Gynecol. 2007;110(3):601–7.
Chan YD, Valenti D, Mansfield HO, Stansby G. Warfarin induced skin necrosis. Br J Surg. 2000;87(3):266–72.
de Boer K, ten Cate JW, Sturk A, Born JJ, Treffers PE. Enhanced thrombin generation in normal and hypertensive pregnancy. Am J Obstet Gynecol. 1989;160(1):95–100.
Dempfle CE. Minor transplancental passage of fondaparinux in vivo. N Engl J Med. 2004;350:1914–5.
Dennis MW, Clough V, Tol CH. Unexpected presentation of type 2N von Willebrand disease in pregnancy. Haemophilia. 2000;6(6):696–7.
Derksen R, DeGroot PG, Nienwenhuis H, Christiaens G. How to treat women with antiphospholipid antibodies in pregnancy. Ann Rheum Dis. 2001;60(1):1–3.
Derksen RH, Khamashta MA, Branch DW. Management of the obstetric antiphospholipid syndrome. Arthritis Rheum. 2004;50(4):1028–39.
DiMinno G, Coppola A, DiMinno MND, Poon M-C. Glanzmann’s thrombasthemia: proposals for management between evidence and open issues. Thromb Haemost. 2009;102:1157–64.
Dizon-Townson D, Miller C, Sibai B, et al. The relationship of the factor V leiden mutation and pregnancy outcomes for mother and fetus. Obstet Gynecol. 2005;106:517–24.
Dossenbach-Glaninger A, van Trotsenburg M, Krugluger W, Dossengach JR, Oberkanins C, Huber J, Hopmeier P. Elevated coagulation factor VIII and the risk for recurrent early pregnancy loss. Thromb Haemost. 2004;91(4):694–9.
Dresang LT, Fontaine P, Leeman L, King VJ. Venous thromboembolism during pregnancy. Am Fam Physician. 2008;77(12):1709–16.
Ecker JL, Solt K, Fitzsimons MG, MacGillivray TE. Case 40-2012: a 43-year-old woman with cardiorespiratory arrest after a cesarean section. N Engl J Med. 2012;367(26):2528–37.
Faught W, Garner P, Jones G, Ivey G. Changes in protein C and protein S levels in normal pregnancy. Am J Obstet Gynecol. 1995;172(1):147–50.
Felbinger TW, Posner M, Eltzchig HK, Kodali BS. Laparoscopic splenectomy in a pregnancy patient with immune thrombocytopenic purpura. Int J Obstet Anesth. 2007;16(3):281–3.
Fraser DG, Moody AR, Morgan PS, et al. Diagnosis of lower-limb deep venous thrombosis: a prospective blinded study of magnetic resonance direct thrombus imaging. Ann Intern Med. 2002;136:89–98.
Gerhardt A, Scharf RE, Beckmann MW, et al. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium. N Engl J Med. 2000;342:374–80.
Gibson PS. Anticoagulants and pregnancy: when are they safe. Cleve Clin J Med. 2009;76(2):113–27.
Gilbert JS, Ryan MJ, LaMarca BB, Sedeek M, Murphy SR, Granger JP. Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction. Am J Physiol Heart Circ Physiol. 2008;294:H541–50.
Gill KK, Kelton JG. Management of idiopathic thrombocytopenic purpura in pregnancy. Semin Hematol. 2000;37(3):275–89.
Ginsberg JS, Brill-Edwards P, Burrows RF, et al. Venous thrombosis during pregnancy: leg and trimester of presentation. Thromb Haemost. 1992;67:519–20.
Gist RS, Stafford IP, Leibowitz AB, Feilin Y. Amniotic fluid embolism. Anesth Analg. 2009;108(5):1599–602.
Glueck CJ, Pranikoff J, Khan N, Riaz K, Chavan K, Raj P, Aumar M, Wang P. High factor XI, recurrent pregnancy loss, enoxaparin. Fertil Steril. 2010;94(7):2828–31.
Greer I, Hunt BJ. Low molecular weight heparin in pregnancy: current issues. Br J Haematol. 2005;128:593–601.
Greer IA, Nelson-Piercy C. Low molecular weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. Blood. 2005;106:401–7.
Heit JA, Sobell JL, Li H, Sommer SS. The incidence of venous thromboembolism among factor V Leiden carriers: a community-based cohort study. J Thromb Haemost. 2005;3:305–11.
Hellgren M, Tangforn L, Abildgaard U. Pregnancy in women with congenital antithrombin III deficiency: experience of treatment with heparin and antithrombin. Gynecol Obstet Invest. 1982;14(2):127–41.
Hutcheon JA, Lisonkova S, Joseph KS. Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynecol. 2011;25(4):391–403.
Kawamata K, Chiba Y, Tanaka R, Higashi M, Nishigami K. Experience of temporary inferior vena cava filters inserted in the perinatal period to prevent pulmonary embolism in pregnant women with deep vein thrombosis. J Vasc Surg. 2005;41(4):652–6.
Kline JA, Williams GW, Hernancez-Nino J. D-dimer concentrations in normal pregnancy: new diagnostic thresholds are needed. Clin Chem. 2005;51:528–829.
Knight M, Tuffnell D, Brocklehurst P, Spark P, Kurinczu JJ, UK Obstetric Surveillance System. Incidence and risk factors for amniotic fluid embolism. Obstet Gynecol. 2010;115(5):910–7.
Ko HH, Yoshida E. Acute fatty liver of pregnancy. Can J Gastroenterol. 2006;20(1):25–30.
Kujovich JL. Von Willebrand disease and pregnancy. J Thromb Haemostast. 2005;3:245–53.
Lee CA, Chi C, Pavord SR, Bolton-Maggs PHB, Pollard D, Hinchcliff-Wood A, Kandir RA. The obstetric and gynecological management of women with inherited bleeding disorders—review with guidelines produced by task force of UK Haemophilia Doctors’ Organization. Haemophilia. 2006;12(4):301–36.
Leonhardt G, Gaul C, Nietsch NJ, Vuerke M, Schleussner E. Thrombolytic therapy in pregnancy. J Thromb Thrombolysis. 2006;21(3):271–6.
Levy JA, Murphy L. Thrombocytopenia in pregnancy. J Am Board Fam Prac. 2002;15(4):290–7.
Lindqvist PG, Svensson PJ, Marsaal K, et al. Activated protein C resistance (FV:Q506) and pregnancy. Thromb Haemost. 1999;81:532–7.
Mannucci PM. How I, treat patients with von Willebrand’s disease. Blood. 2001;97(7):1915–9.
Martin Jr JN, Rinehart BK, May WL, Magann EF, Terrone DA, Blake PG. The spectrum of severe pre-eclampsia: comparative analysis by HELLP syndrome classification. Am J Obstet Gynecol. 1999;180(6 Pt 1):1373–84.
Martin-Salces M, Jimenez-Yuste V, Alvarez MT, Quintana M, Hernandez-Navarro F. Review: factor XI deficiency: review and management in pregnant women. Clin Appl Thromb Hemost. 2010;16(2):209–13.
Meslovitz S, Many A, Landsberg JA, Varon D, Lessing J, Kupferminc M. The safety of low molecular weight heparin therapy during labor. J Matern Fetal Neonatal Med. 2005;17(1):39–43.
Miyakis S, Lockshin M, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite anti-phospholipid syndrome (APS). J Thromb Haemost. 2006;4(2):295–306.
Monte S, Lyons G. Peripartum management of a patient with Glanzmann’s thrombasthemia using Throm-belastograph. Br J Anaesth. 2002;88:734–8.
Moore J, Baldisseri MR. Amniotic fluid embolism. Crit Care Med. 2005;33(10 Suppl):S279–85.
Myers B, Pavord S, Keen L, Hill M, Dolan G. Pregnancy outcome in factor XI deficiency: incidence of miscarriage, antenatal and postnatal hemorrhage in 33 women with factor XI deficiency. BJOG. 2007;114(5):643–6.
Neunert C, Lim W, Crowther M, Cohen A, Solberg Jr L, Crowther MA. The American Society of Hematology 2011 evidence-based guideline for immune thrombocytopenia. Blood. 2011;117(16):4190–207.
Osinbowale O, Al Malki M, Schade A, Bartholomew JR. An algorithm for managing warfarin resistance. Cleve Clin J Med. 2009;76(12):724–30.
Pahade J, Litmanovich D, Pedrosa I, Romero J, Bankier A, Boiselle P. Imaging pregnant patients with suspected pulmonary embolism: what the radiologist needs to know. RadioGraphics. 2009;29:639–54.
Peaceman AM, Katz AR, Laville M. Bernard Soulier syndrome complicating pregnancy: a case report. Obstet Gynecol. 1989;73(3):457–9.
Phillips LE, McLintock C, Pollock W, Galt S, Popham P, Jankelowitz G, Ogle R, Cameron PA. Recombinant activated factor VII in obstetric hemorrhage: experiences from the Australian and New Zealand Haemostasis Registry. Anesth Analg. 2009;109(6):1908–15.
Poon M-C, D’Oiron R, Von Depka M, Khair K, Negrier C, Karafoulidou A, Huth-Khehne A, Morfina M. Prophylactic and therapeutic recombinant VIIa administration to patients with Glanzmann’s thrombasthemia: results of an international survey. J Thromb Haemost. 2004;2:1096–103.
Prandoni P, Noventa F, Ghirarduzzi A, Pengo V, Bernardi E, Pesavento R, Iotti M, Tormene D, Simioni P, Pagnan A. The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with proximal deep vein thrombosis or pulmonary embolism. Haematologica. 2007;91:199–205.
Prandoni P, Piovella C, Spiezia L, Dalla Valle F, Pesquento R. Optimal duration of anticoagulation in patients with venous thromboembolism. Indian J Med Res. 2011;134(1):15–21.
Rahini G, Rellecke S, Mallmann P, Nawroth F. Course of pregnancy and birth in a patient with Bernard Soulier syndrome—a case report. J Perinat Med. 2005;33:264–6.
Ray JG. DDAVP use during pregnancy: an analysis of its safety for mother and child. Obstet Gynecol Surv. 1998;53:450–5.
Roberts JM, et al. Hypertension in pregnancy: Executive summary. Obstetrics and Gynecology. 2013;122(5):1122–31.
Saade G, Hornsi R, Seoud M. Bernard-Soulier syndrome in pregnancy: a report of four pregnancies in one patient, and review of the literature. Eur J Obstet Gynecol Reprod Biol. 1991;40(2):149–52.
Samuel A, Lin C, Parviainen K, Jeyabalan A. Expectant management of preeclampsia superimposed on chronic hypertension. J Matern Fetal Neonatal Med. 2011;24(7):907–11.
Scarsbrook AF, Evans AL, Owen AR, Gleeson FV. Diagnosis of suspected venous thromboembolic disease in pregnancy. Clin Radiol. 2006;61:1–12.
Schindler D, Graham TP. Warfarin overdose in a breast-feeding woman. West J Emerg Med. 2011;12(2):216–7.
Schulman S, Tengborn L. Treatment of venous thromboembolism in patients with congenital deficiency of antithrombin III. Thromb Haemost. 1992;68(6):634.
Sibai BM. The HELLP syndrome: much ado about nothing? Am J Obstet Gynecol. 1990;162(2):311–6.
Sibai BM. Chap 33: Hypertension. In: Table SG, Niebyl JR, Simpson JL, editors. Obstetrics—normal and problem pregnancies. 5th ed. Philadelphia, PA: Elsevier Churchill Livingstone; 2007.
Sloan N, Durocher J, Aldrich T, Blum J, Winikoff B. What measured blood loss tell us about postpartum bleeding: a systematic review. BJOG. 2010;117:788–800.
Spencer J, Rosengren S. Hermansky-Pudlak syndrome in pregnancy. Am J Perinatol. 2009;26(9):617–9.
Suarez B, Alves K, Senat MV, Fromageot J, Fischer C, Rosenberg P, Ville Y. Abdominal pain and pre-eclampsia. Sonographic findings in the maternal liver. J Ultrasound Med. 2002;21:1077–83.
Tincani A, Branch W, Lefy RA, Piette JC, Carp H, Rai RS, Khamashta M, Schoelfeld Y. Treatment of pregnant patients with antiphospholipid syndrome. Lupus. 2003;12(7):524–9.
Van Wersch JWJ, Ubachs JMH. Blood coagulation and fibrinolysis during normal pregnancy. Eur J Clin Chem Clin Biochem. 1991;29:45–50.
Varga EA, Sturm AC, Misita CP, Moll S. Homocysteine and MTHFR mutations. Circulation. 2005;11:e289–93.
Vitale N, DeFeo M, DeSanto LS, Pollice A, Tedesco N, Cotrufo M. Does-dependent fetal complications of warfarin in pregnant women with mechanical heart valves. J Am Coll Cardiol. 1999;33(6):1637–41.
Webert KE, Mittal R, Sigouin C, Heddle NM, Kelton JG. A retrospective 11-year analysis of obstetric patients with immune thrombocytopenic purpura. Blood. 2003;102(13):4306–11.
Weinstein L. Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy. Am J Obstet Gynecol. 1982;142(2):159–67.
White RH, Chan WS, Shou H, Ginsberg JS. Recurrent venous thromboembolism after pregnancy associated versus unprovoked thromboembolism. Thromb Haemost. 2008;100(2):246–52.
Widurer M, Villar J, Benigni A, Conde-Agudelot A, Karamanchi SA, Lindheimer M. Mapping the theories of preeclampsia and the role of angiogenic factors: a systematic review. Obstet Gynecol. 2007;109:168–80.
Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, Brey R, Derksen R, Harris EN, Hughes GR, Triplett DA, Khamashta MA. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum. 1999;42(7):1309–11.
Winer-Muram HT, Boone JM, Brown HL, et al. Pulmonary embolism in pregnant patients: fetal radiation dose with helical CT. Radiology. 2002;224:487–92.
Wysowski DK, Talarico L, Bacsanyi J, Botstein P. Spinal and epidural hematoma and low molecular weight heparin. N Engl J Med. 1998;338:1774–5.
Yamada T, Yamada H, Morikawa M, Kato EH, Kishida T, Ohnaka Y, Nikaido H, Ozawa T, Fujimoto S. Management of pregnancy with congenital antithrombin III deficiency: two case reports and a review of the literature. J Obstet Gynaecol Res. 2001;27(4):189–97.
Zhou Y, McMaster M, Woo K, Janatpour M, Perry J, Karpanen T, Alitalo K, Damsky C, Fisher SJ. Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am J Pathol. 2002;160:1405–23.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Lichtin, A., Philipson, E.H. (2014). Pregnancy. In: Lichtin, A., Bartholomew, J. (eds) The Coagulation Consult. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-9560-4_17
Download citation
DOI: https://doi.org/10.1007/978-1-4614-9560-4_17
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-9559-8
Online ISBN: 978-1-4614-9560-4
eBook Packages: MedicineMedicine (R0)